The herpes simplex virus type 1 UL37 gene encodes a protein with an Mr of 120K that is produced at late times after infection. To study the properties of this protein we have linked a 10 amino acid epitope derived from a human cytomegalovirus protein to the UL37 polypeptide coding sequences by inserting an oligonucleotide at a SpeI site that is unique in the virus genome and lies close to the 3' end of the open reading frame. From studies on the resultant virus recombinant using a monoclonal antibody that recognizes the inserted epitope we find that, contrary to a previous report, the UL37 protein is a structural component of both virions and L particles and is present in the tegument of virus particles. Indirect immunofluorescence analysis revealed that the protein is distributed throughout infected cells but is more abundant in the cytoplasm than the nucleus,
The herpes simplex virus type 1 UL37 gene encodes a protein with an Mr of 120K that is produced at late times after infection. To study the properties of this protein we have linked a 10 amino acid epitope derived from a human cytomegalovirus protein to the UL37 polypeptide coding sequences by inserting an oligonucleotide at a SpeI site that is unique in the virus genome and lies close to the 3' end of the open reading frame. From studies on the resultant virus recombinant using a monoclonal antibody that recognizes the inserted epitope we find that, contrary to a previous report, the UL37 protein is a structural component of both virions and L particles and is present in the tegument of virus particles. Indirect immunofluorescence analysis revealed that the protein is distributed throughout infected cells but is more abundant in the cytoplasm than the nucleus, The herpes simplex virus type 1 (HSV-1) genome contains at least 74 open reading frames (ORFs) that specify virus gene products . The characterization of these gene products, and of their functions and interactions, provides a valuable insight into the complex processes that take place during the virus life cycle. Studies on the HSV-1 UL37 gene product have shown that it encodes a protein with an Mr of 120K which is phosphorylated soon after translation (Shelton et al., 1990; Albright & Jenkins, 1993) . Analysis of the production of the protein at various times after infection and in the presence of the DNA synthesis inhibitor phosphonacetic acid has indicated that UL37 is regulated as a 71 gene (Shelton et al., 1990) . The protein co-elutes from single-and double-stranded DNA columns with the major DNA-binding protein, ICP8 (encoded by gene UL29), leading to the suggestion that interaction between the UL37 protein and ICP8 accounts for the apparent DNA-binding ability of the UL37 protein (Albright & Jenkins, 1993) . In Western blot analysis, the UL37 protein was not detected in HSV-1 virions and hence was designated a non-structural protein (Shelton et al., 1990) . Contrary to these previous findings, we now demonstrate that the protein encoded by UL37 is present in virus particles.
From analysis of the nucleotide sequence of HSV-1 DNA , the virus genome contains an unique SpeI restriction enzyme site which lies 11 bp upstream from the 3' terminus of the UL37 ORF. To facilitate studies on the properties of the protein encoded by UL37, we linked an epitope tag at the C terminus of the protein by insertion of an oligonucleotide at this SpeI site. The oligonucleotide comprised sequences from the SpeI site to the last codon of the UL37 ORF followed by sequences encoding a 10 amino acid epitope from the human cytomegalovirus (HCMV) UL83 gene that is recognized by the monoclonal antibody (MAb) 9220 (Fig. 1 a; Weiner et al., 1985; K. Liefkens & J. McLauchlan, unpublished) . Thus, incorporation of the oligonucleotide in the correct orientation into the viral genome should generate a recombinant in which the UL37 ORF is extended by 10 amino acids as compared with the UL37 ORF in the parental viral DNA (Fig. l a) . In addition, the oligonucleotide was designed such that, following insertion into viral DNA, the SpeI site would be lost and a novel NheI site would be generated in the virus genome (Fig. l a) . Following ligation of the oligonucleotide into HSV-1 strain 17 viral DNA that had been digested with SpeI, BHK C13 cells were transfected with the ligation products. Individual plaques were picked and screened with MAb 9220 by Western blotting to detect protein tagged with the HCMV epitope. Results indicated that a number of plaques expressed a protein of approximately 120K that was recognized by MAb 9220 (data not shown). Plaques were purified to homogeneity and one recombinant, termed vUL37, was selected for further study. Southern blot analysis confirmed that vUL37 viral DNA lacked a SpeI site but had gained a novel NheI site in the predicted location (data not shown). To show that MAb 9220 could specifically detect epitope-tagged UL37 protein, extracts were analysed from cells infected for 24 h with vUL37 and HSV-1 strain 17. As a further control, extracts prepared from cells infected with another virus recombinant, vPP65, Cell extracts were electrophoresed on a 7.5% polyacrylamide gel, transferred to a nitrocellulose membrane (Towbin et al., 1979) and probed with MAb 9220 (1:1000 dilution). were also examined; this HSV-1 recombinant expresses the pp65 matrix protein that is encoded by H C M V UL83 and from which the epitope tag sequence is derived (J. McLauchlan & F. J. Rixon, unpublished) . Western blot analysis showed that the antibody detected a major product of 120K in vUL37-infected cells and a 65K protein in vPP65-infected cells ( Fig. 1 b, lanes 1 and 3). However, no protein was recognized by the antibody in either HSV-1 strain 17-or mock-infected cells ( Fig. 1 b, lanes 2 and 4). Based on our Western blot and D N A analysis, we conclude that the 120K protein corresponds to the tagged UL37 protein. In addition to the 120K product, MAb 9220 also detected a minor species of 85K in vUL37-infected cell extracts (Fig. lb, lane 1) . We presume that this species represents the C-terminal portion of the UL37 protein and is probably produced by either proteolytic cleavage of the full-length 120K protein or translational initiation at an internal A T G within the UL37 ORF. In vitro translation of R N A selected from this region of the virus genome has been shown to give rise to products of 120K and 85K (Anderson et al., 1981) . These may correspond to the polypeptides detected with MAb 9220.
To investigate whether the UL37 protein was a structural component, virus particles produced by the recombinant were separated on a 5 to 15% Ficoll gradient (Szilfigyi & Cunningham, 1991) and analysed for the presence of tagged UL37 protein. These gradients separate vlrions from other enveloped particles released from HSV-l-infected cells which are termed L particles. L particles lack nucleocapsids but do contain the major tegument and envelope components present in virions (Szilfigyi & Cunningham, 1991; McLauchlan & Rixon, 1992) . Approximately 15 gg of purified virions and L particles produced by vUL37 and HSV-1 strain 17 were electrophoresed on a polyacrylamide gel and transferred to a nitrocellulose membrane. Fig. 2 (a) shows that MAb 9220 readily detected a 120K protein corresponding to the tagged UL37 protein in vUL37 virions and L particles ( Fig. 2 a, lanes 3 and 4) whereas no equivalentsized product was recognized in HSV-1 strain 17 virus particles (Fig. 2a, lanes 1 and 2) . To confirm that UL37 protein made by vUL37 was present in virus particles and that its detection was not due to smearing of nonstructural proteins through the gradient, virions and L particles released from vUL37-infected cells were separated on a Ficoll gradient and 300 gl fractions were collected from below the virion band to the top of the gradient. A 25 gl sample from each fraction was analysed by Western blotting using MAb 9220 to probe the nitrocellulose membrane for the presence of tagged UL37 protein (Fig. 3a) . This revealed that the UL37 protein was most abundant in fractions 4 to 8 whereas fractions 9 to 17 contained detectable but lower quantities of the protein. Beyond fraction 17, the amount of UL37 protein detected decreased significantly and it was barely detectable at the top of the gradient. To identify those samples in the gradient which contained virus particles, the nitrocellulose membrane was reprobed with M A b LP1 which recognizes VP16 (McLean et al., 1982) , the 65K protein encoded by UL48 and a major component of the tegument in both virions and L particles (Heine et al., 1974; Szilfigyi & Cunningham, 1991; McLauchlan & Rixon, 1992) . The presence of VP 16 in the gradient fractions paralleled the detection of the UL37 protein (Fig. 3b) . Further Western blot analysis of these samples showed that a M A b which recognizes the 65K non-structural protein encoded by gene UL42 (Marsden et al., 1987; Parris et al., 1988; Y a o & Courtney, 1989) detected this protein only in fraction 24 at the top of the gradient (data not shown). These data therefore demonstrate that the tagged UL37 protein is a structural component o f vUL37 virus particles. The location of the tagged UL37 protein in vUL37 virus particles was analysed by detergent treatment of virions and L particles followed by separation o f the solubilized envelope components from the other structural proteins by using centrifugation (McLauchlan & (Rixon & McLauchlan, 1993) and separated on a Ficoll gradient. Samples were collected from below the virion band (fraction 1) to the top of the gradient (fraction 24). Lane 25 contains proteins from an extract prepared from cells infected with vUL37 at an m.o.i, of 10 for 24 h. Proteins were separated on a 9 % polyacrylamide gel and then transferred to a nitrocellulose membrane. The antibodies used were MAb 9220 in (a) and the VP16-specific antibody LP1 in (b); both antibodies were used at a dilution of 1 : 1000. Prior to analysis with LP1 MAb, the bound MAb 9220 was removed as described in the legend to Fig. 2 . The Mrs of the proteins detected by each antibody are indicated. . Western blot analysis showed that tagged UL37 protein was found almost exclusively in pelleted material from both virions and L particles (Fig. 2a , lanes 5 to 8). To demonstrate that NP40 treatment had efficiently solubilized the glycoproteins in the envelope o f virus particles, the membrane was re-probed with M A b 4846 which recognizes HSV-1 gD (A. Cross, personal communication). Our results indicated that, consistent with previous reports on the efficiency with which glycoproteins are solubilized by detergent treatment (Yao & Courtney, 1989) , greater than 9 0 % of gD is present in the supernatant fraction as compared with the pelleted material (Fig. 2 b , compare lane 5 with lane 6 and lane 7 with lane 8). Since there is no evidence that UL37 protein is a c o m p o n e n t of capsids (Rixon et al., 1990; Davison et at., 1992) and the pelleted material from detergent-treated L particles contains principally tegument components, we conclude that the tagged UL37 protein is located in the tegument. To determine whether the tagged UL37 protein corresponded to a band that could be identified in the polypeptide profile of virus particles, Western blot analysis was performed using M A b 9220 on the pelleted material from NP40-treated vUL37 virions and L particles (Fig. 4a) . Alignment o f the polypeptide recognized by the antibody with the profile of radiolabelled proteins transferred to the membrane demonstrated that tagged UL37 protein co-migrated with a band in both v U L 3 7 virions and L particles with an Mr of approximately 120K which was not removed by detergent treatment (Fig. 4a, virions and L particles (Fig. 4a, lanes 1 and 4) . The mobilities of the species within these bands relative to proteins in untreated virus particles was further examined (Fig. 4b) . The 120K band containing the UL37 protein in the pelleted material co-migrated with a major component of virus particles (Fig. 4b , compare lanes 1 and 6 with lanes 3 and 4). Previous experiments have shown that this band in virions contains the major envelope glycoproteins gB, gC and gH (Buckmaster et al., 1984; Yao & Courtney, 1989 and, in contrast to the tagged UL37 protein (see Fig. 2 ), these glycoproteins are solubilized by detergent treatment (Fig. 4 b, lanes 2 and 5; Yao & Courtney, 1989 McLauchlan & Rixon, 1992; Zhang & McKnight, 1993) . The presence of these major virion components of similar size to UL37 may have precluded its previous identification as a virion protein.
Comparison of the pelleted material from vUL37 and HSV-1 strain 17 virions showed that the upper component of the 120K band had slightly decreased mobility in the vUL37 sample (Fig. 4b , compare lanes 3 and 4) and this finding was consistent with the increased length of the UL37 ORF in this virus (see Fig. 1 a) .
To analyse the cellular distribution of tagged UL37 protein, BHK C13 cells on 13 mm coverslips were infected with vUL37 at an m.o.i, of 0.1 and analysed with MAb 9220 at various times after infection. As a control, a parallel series of coverslips were infected with HSV-1 strain 17. Our analysis revealed that there was no specific fluorescence in the HSV-1 strain 17-infected cells (Fig.  5b) . In the vUL37-infected cells, UL37 protein was distributed throughout the cell, however more of the protein was detected in the cytoplasm than in the nucleus (Fig. 5a ). The tagged protein was first detected at 9 h post-infection and the distribution remained constant throughout infection (data not shown).
In this report, we have linked an epitope tag to the C terminus of the UL37 protein and have shown that this tagged protein is present in both virions and L particles and is located in the tegument. This result conflicts with a previous study that indicated that UL37 protein was not a structural component (Shelton et al., 1990) . Two pieces of evidence indicate that the presence of the tagged UL37 protein in virus particles is not a consequence of the epitope tag at the C terminus of the protein. Firstly, linkage of the epitope to the chloramphenicol acetyltransferase (CAT) coding sequences does not result in the incorporation of CAT protein into virus particles (J. Leslie, F. J. Rixon & J. McLauchlan, unpublished) , and secondly, comparison of the polypeptide profiles of the structural components of HSV-1 strain 17 and vUL37 revealed no novel polypeptide of the appropriate size (120K). Fig. 4(b) suggests that the band containing the UL37 protein in the pelleted material from virus particles may consist of more than one species although we do not know whether these might represent distinct structural components, such as ICP0 (Yao & Courtney, 1992) , or other forms of the UL37 polypeptide.
The identification of UL37 as a tegument component adds to the list of virus-encoded structural proteins. In common with several other tegument proteins, the UL37 protein is phosphorylated in infected cells (Albright & Jenkins, 1993) . A number of these tegument components also can be phosphorylated in vitro using purified preparations of virus particles (Lemaster & Roizman, 1980; Coulter et al., 1993; Zhang & McKnight, 1993) . Eighteen hours after infection, cells were fixed by incubation in acetone for 20 min at -20 °C. Following rehydration and washing in PBS containing 1% newborn calf serum, coverslips were incubated with MAb 9220 (1:300 dilution) for 2 h at room temperature. Detection of primary antibody was performed with a fluorescein conjugate (1 : 100 dilution) for 2 h at room temperature. After washing, coverslips were mounted and examined under a Nikon microphot-SA fluorescence microscope.
Interestingly, previous studies had indicated that & vitro p h o s p h o r y l a t i o n gave rise to a p r o d u c t that co-migrated with gB (Coulter et al., 1993) . Our recent findings show that a 120K p h o s p h o r y l a t e d p r o d u c t is m a d e in vitro using the pelleted fraction from detergent-treated HSV-1 strain 17 or vUL37 virus particles (J. M c L a u c h l a n & H . W . M . Moss, unpublished). Since the pelleted material lacks significant quantities of glycoproteins, it is p r o b a b l e that this /'n vitro p h o s p h o r y l a t e d p r o d u c t represents U L 3 7 protein in the virus tegument.
The function of the UL37 protein during virus infection is not known. It has been suggested that it m a y interact with ICP8, the m a j o r D N A -b i n d i n g protein, and thus perhaps m a y alter its function (Albright & Jenkins, 1993) . Identification of UL37 protein as a tegument c o m p o n e n t suggests that the protein m a y have a structural role and therefore p r e s u m a b l y interacts not only with ICP8, a non-structural species, but also with other structural components. The presence o f U L 3 7 protein in L particles as well as in virions indicates that i n c o r p o r a t i o n o f the polypeptide into virus particles is not dependent on interaction with the nucleocapsid.
It is interesting that the U L 3 7 protein is detected in both nuclear and cytoplasmic c o m p a r t m e n t s . Analysis o f cells transfected with a plasmid expressing UL37 protein reveals that the distribution is the same in the absence o f other virus gene products (data not shown). Recent studies on the V P 1 / 2 tegument species encoded by U L 3 6 have d e m o n s t r a t e d that it too is distributed between nucleus and c y t o p l a s m ( M c N a b b & Courtney, 1992a, b) . Since at least these two c o m p o n e n t s of the tegument are not restricted to the nucleus, the precise site at which tegument assembly occurs remains obscure. A d d i t i o n a l studies on the properties of UL37 and its involvement in tegument assembly m a y provide further insights into the mechanisms of tegumentation and virus particle morphogenesis.
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